Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Reduning Granules
- Development stage
- Unknown
- Lead developer
- Lianyungang Kanion
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Reduning Granules is a Traditional Chinese Medicine (TCM) developed by Jiangsu Kanion Pharmaceutical Co., Ltd., formulated as an oral alternative to the established Reduning Injection. It is composed of extracts from three primary medicinal herbs: *Artemisia annua* (Sweet Wormwood), *Lonicera japonica* (Japanese Honeysuckle), and *Gardenia jasminoides* (Cape Jasmine). The drug is primarily indicated for the treatment of upper respiratory tract infections, including influenza, characterized by symptoms such as high fever, cough, and sore throat associated with "heat-toxin" syndromes in TCM theory. Pharmacologically, Reduning Granules exerts antipyretic, anti-inflammatory, and antiviral effects by modulating the production of pro-inflammatory cytokines and inhibiting inflammatory mediators. It was approved by China's National Medical Products Administration (NMPA) as a modern TCM drug.
- Brand names
- Reduning
- Other names
- Reduning Keli热毒宁颗粒
02
Targets
IL-6 (Interleukin 6)
Beyond the preview
Go deeper on Reduning Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Reduning Granules.